CON# IDIQ-NIH-CANC-PHARM-EVAL
    Sponsoring Agency HHS
    POP 7/1/16 - 6/30/21 (4 years)

Description

Preclinical Pharmacokinetic and Pharmacology Evaluations of Agents Being Developed for Cancer Patients

  • $12k Aggregate Dollars Obligated
  • $12k Aggregate Base & Exercised Options
  • $12k Aggregate Base & All Options (Ceiling)

Market Stats Related Contracts